Topoisomerase inhibition by lucanthone, an adjuvant in radiation therapy
- 15 March 1997
- journal article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 37 (5) , 1133-1137
- https://doi.org/10.1016/s0360-3016(97)00113-2
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Abasic Sites Stimulate Double-stranded DNA Cleavage Mediated by Topoisomerase IIJournal of Biological Chemistry, 1995
- DNA topoisomerase-trapping antitumour drugsEuropean Journal Of Cancer, 1992
- DNA TOPOISOMERASE POISONS AS ANTITUMOR DRUGSAnnual Review of Biochemistry, 1989
- Combined treatment with radioestradiol-lucanthone in mouse C3HBA mammary adenocarcinoma and with estradiol-lucanthone in an estrogen bioassayInternational Journal of Radiation Oncology*Biology*Physics, 1981
- Lucanthone as a radiosensitizing agent in the treatment of carcinoma of the cervixInternational Journal of Radiation Oncology*Biology*Physics, 1978
- DNA intercalating agents as adjuvants in radiation therapyInternational Journal of Radiation Oncology*Biology*Physics, 1978
- The Adjuvant Effect of Lucanthone (Miracil D) in Clinical Radiation TherapyRadiology, 1975
- Combined Lethal Effects of Lucanthone (Miracil D) and Total-Body Irradiation in MiceRadiology, 1972
- Reversible inhibition of ribosomal RNA synthesis in HeLa by lucanthone (Miracil D) with continued synthesis of DNA-like RNAJournal of Cellular Physiology, 1969
- Actinomycin D: Suppression of Recovery in X-Irradiated Mammalian CellsScience, 1964